NEWS

Clarifying and Strengthening the Regulation of Medical Device Software Including Artificial Intelligence (AI)

The regulator’s mid-2025 review acknowledges that the existing, technology-agnostic, risk-based framework remains fundamentally appropriate for SaMD and AI-enabled medical devices ...more

News

December 10, 20255 min read

Clarifying and Strengthening the Regulation of Medical Device Software Including Artificial Intelligence (AI)

AusBiotech 2025 International Conference

AusBiotech 2025 offered a valuable reflection point for the biotechnology sector, particularly regarding GMP and regulatory compliance. ...more

News ,GMP

December 01, 20253 min read

AusBiotech 2025 International Conference

Temporary GMP Exemptions for Bacteriophage Therapies in Australia

The proposed temporary GMP exemption by the TGA for personalised bacteriophage therapy manufacture in Australia marks a significant regulatory development for the emerging phage‑therapy sector. ...more

News

November 02, 20256 min read

Temporary GMP Exemptions for Bacteriophage Therapies in Australia

New Regulations to Strengthen Medical Device Patient Safety

The introduction of mandatory reporting requirements for medical device-related adverse events marks a significant step forward in enhancing patient safety in Australia. ...more

News

October 26, 20254 min read

New Regulations to Strengthen Medical Device Patient Safety

Understanding the Therapeutic Goods Legislation Amendment Effective from 1 October 2025

Understanding the Therapeutic Goods Legislation Amendment Effective from 1 October 2025 ...more

Therapeutic Goods Administration ,News

October 13, 20253 min read

Understanding the Therapeutic Goods Legislation Amendment Effective from 1 October 2025

Common Mistakes That Slow Regulatory Approvals—And How to Avoid Them

For therapeutic goods manufacturers, biotechnology companies, and testing laboratories, navigating the regulatory landscape can be complex and challenging. ...more

News

October 08, 20255 min read

Common Mistakes That Slow Regulatory Approvals—And How to Avoid Them
Back to Home